US 9161936
Laquinimod for treatment of GABA mediated disorders
granted A61KA61K31/4704A61P
Quick answer
US patent 9161936 (Laquinimod for treatment of GABA mediated disorders) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4704, A61P, A61P25/00, A61P25/08